Regencell Bioscience (RGC) has had the highest return since March 6, 2025 by a mid-cap US stock, returning 13,627.3%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 13,627.27% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,228.13% |
Abivax SA American Depositary Shares (ABVX) | 931.63% |
Ondas (ONDS) | 783.51% |
Opendoor Technologies (OPEN) | 640.34% |
Forward Industries (FORD) | 503.93% |
D-Wave Quantum (QBTS) | 407.3% |
American Bitcoin (ABTC) | 406.15% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 399.14% |
Celcuity LLC (CELC) | 395.59% |
Uniqure (QURE) | 365.78% |
Energy Fuels (UUUU) | 312.59% |
Mineralys Therapeutics, Inc Common Stock (MLYS) | 305.58% |
Quantum Computing (QUBT) | 301.29% |
Cidara Therapeutics (CDTX) | 287.23% |
Centrus Energy (LEU) | 274.66% |
Power Solutions International, Inc Common Stock (PSIX) | 251.58% |
TMC the metals (TMC) | 243.78% |
Sharplink Gaming (SBET) | 233.33% |
Pagaya Technologies (PGY) | 211.79% |
Terawulf (WULF) | 206.8% |
ViaSat (VSAT) | 206.46% |
American Superconductor (AMSC) | 204.26% |
Sibanye Gold Ltd ADR (SBSW) | 203.26% |
Applied Digital (APLD) | 197.81% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
